Dmitry Zamansky is the Chief Product & Technology Officer at American Well Corp (AMWL), where he recently sold 5,575 shares of Class A common stock on April 1, 2026, at $5.30 per share to cover tax obligations from vesting restricted stock units, retaining 241,080 shares afterward.(

Zamansky brings over a decade of experience from Amazon, where he held leadership roles in product management, engineering, and technology, including founding and leading AWS Health AI to provide AI tools for healthcare and life sciences customers, and serving as general manager for platform core services overseeing ad business technology teams.( He joined Amwell in March 2025, succeeding Vaughn Paunovich, to lead the company's product and R&D organizations, focusing on its technology-enabled care platform for payers and health systems.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.